1NHG | D:366-418; D:366-418; D:366-418; D:366-418 | CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL-ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN |
1NHW | D:366-418; D:366-418; D:366-418; D:366-418 | CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL-ACYL-CARRIER-PROTEIN REDUCTASE |
1NNU | D:366-418; D:366-418; D:366-418; D:366-418 | CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL-ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN ANALOG |
1VRW | B:366-418; B:366-418; B:366-418; B:366-418 | CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL-ACYL-CARRIER-PROTEIN REDUCTASE WITH NADH |
1ZW1 | B:366-418; B:366-418; B:366-418; B:366-418 | SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REDUCTASE. PART 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES |
2NQ8 | D:366-418; D:366-418; B:104-325; B:104-325 | MALARIAL ENOYL ACYL ACP REDUCTASE BOUND WITH INH-NAD ADDUCT |
2OL4 | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TRICLOSAN REDUCTASE |
2OOS | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TRICLOSAN REDUCTASE |
2OP0 | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TRICLOSAN REDUCTASE |
2OP1 | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TRICLOSAN REDUCTASE |
1UH5 | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF ENOYL-ACP REDUCTASE WITH TRICLOSAN AT 2.2ANGSTROMS |
1V35 | B:367-418; B:367-418; B:367-418; B:367-418 | CRYSTAL STRUCTURE OF EOYL-ACP REDUCTASE WITH NADH |
1ZSN | B:366-418; B:366-418; B:366-418; B:366-418 | SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REDUCTASE. PART 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES |
1ZXB | B:366-418; B:366-418; B:366-418; B:366-418 | SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL ANALYSIS OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REDUCTASE. PART 1:4'-SUBSTITUTED TRICLOSAN DERIVATIVES |
3LSY | B:367-418; B:367-418; B:367-418; B:367-418 | ENOYL-ACP REDUCTASE FROM PLASMODIUM FALCIPARUM (PFENR) IN COMPLEX WITH TRICLOSAN VARIANT T0 |
3LT0 | B:367-418; B:367-418; B:367-418; B:367-418 | ENOYL-ACP REDUCTASE FROM PLASMODIUM FALCIPARUM (PFENR) IN COMPLEX WITH TRICLOSAN VARIANT T1 |
3LT1 | B:367-418; B:367-418; B:367-418; B:367-418 | ENOYL-ACP REDUCTASE FROM PLASMODIUM FALCIPARUM (PFENR) IN COMPLEX WITH TRICLOSAN VARIANT T2 |
3LT4 | B:367-418; B:367-418; B:367-418; B:367-418 | ENOYL-ACP REDUCTASE FROM PLASMODIUM FALCIPARUM (PFENR) IN COMPLEX WITH TRICLOSAN VARIANT PB4 |